Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.

Saved in:

Bibliographic Details
Title:	Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.
Authors:	Pfeifer, H¹, Wassmann, B¹, Bethge, W², Dengler, J³, Bornhäuser, M⁴, Stadler, M⁵, Beelen, D⁶, Vucinic, V⁷, Burmeister, T⁸, Stelljes, M⁹, Faul, C², Dreger, P³, Kiani, A⁴, Schäfer-Eckart, K¹⁰, Schwerdtfeger, R¹¹, Lange, E¹², Kubuschok, B¹³, Horst, H A¹⁴, Gramatzki, M¹⁵, Brück, P¹
Source:	Leukemia (08876924). Jun2013, Vol. 27 Issue 6, p1254-1262. 9p. 6 Charts, 3 Graphs.
Database:	Academic Search Ultimate

Description
ISSN:	08876924
DOI:	10.1038/leu.2012.352